REFERENCE

Just for reference, I'd like to point you all to a company called Orthocell (OCC). They are a biotech company at a very similar stage to Memphasys (even a bit further away from commercialisation). Their estimated addressable market is $900 million, while Memphasys is 1.2 billion (see Memphasys website). All other stats are extremely similar.

OCC currently has a market cap of 75 million. That's over 4 times as much as Memphasys.

There is no reason for MEM share price to not already be 12 cents. I'm glad Memphasys is starting to get some attention but far out is it still undervalued. I can't think of a reason why you would sell at current price, I suppose it's just the day traders who purchased at the capital raising...?

Anyway I feel like I'm just talking to myself here on HotCopper. Unsure why we get thousands of views but only a few people talking...

Good luck to all.